Effect of an Herbal-Based Injection on 28-Day Mortality in Patients With Sepsis: The EXIT-SEP Randomized Clinical Trial

医学 败血症 传统医学 内科学
作者
Songqiao Liu,Chen Yao,Jianfeng Xie,Hong Liu,Hongliang Wang,Zhaofen Lin,Bingyu Qin,Difen Wang,Weihua Lü,Xiaochun Ma,Yan Liu,Ling Liu,Chi Zhang,Lei Xu,Ruiqiang Zheng,Feihu Zhou,Zhongmin Liu,Guoqiang Zhang,Lixin Zhou,Jian Liu
出处
期刊:JAMA Internal Medicine [American Medical Association]
卷期号:183 (7): 647-647 被引量:112
标识
DOI:10.1001/jamainternmed.2023.0780
摘要

Importance: Previous research has suggested that Xuebijing injection (XBJ), an herbal-based intravenous preparation, may reduce mortality among patients with sepsis. Objective: To determine the effect of XBJ vs placebo on 28-day mortality among patients with sepsis. Design, Setting, and Participants: The Efficacy of Xuebijing Injection in Patients With Sepsis (EXIT-SEP) trial was a multicenter, randomized double-blind, placebo-controlled trial conducted in intensive care units at 45 sites and included 1817 randomized patients with sepsis (sepsis 3.0) present for less than 48 hours. Patients aged 18 to 75 years with a Sequential Organ Failure Assessment score of 2 to 13 were enrolled. The study was conducted from October 2017 to June 2019. The final date of follow-up was July 26, 2019. Data analysis was performed from January 2020 to August 2022. Interventions: The patients were randomized to receive either intravenous infusion of XBJ (100 mL, n = 911) or volume-matched saline placebo (n = 906) every 12 hours for 5 days. Main Outcomes and Measures: The primary outcome was 28-day mortality. Results: Among the 1817 patients who were randomized (mean [SD] age, 56.5 [13.5] years; 1199 [66.0%] men), 1760 (96.9%) completed the trial. In these patients, the 28-day mortality rate was significantly different between the placebo group and the XBJ group (230 of 882 patients [26.1%] vs 165 of 878 patients [18.8%], respectively; P < .001). The absolute risk difference was 7.3 (95% CI, 3.4-11.2) percentage points. The incidence of adverse events was 222 of 878 patients (25.3%) in the placebo group and 200 of 872 patients (22.9%) in the XBJ group. Conclusions and Relevance: In this randomized clinical trial among patients with sepsis, the administration of XBJ reduced 28-day mortality compared with placebo. Trial Registration: ClinicalTrials.gov Identifier: NCT03238742.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
包容的墨镜完成签到,获得积分10
刚刚
bestow发布了新的文献求助10
1秒前
1秒前
我是老大的应助被lq采纳,获得10
1秒前
西语发布了新的文献求助10
2秒前
mask发布了新的文献求助10
3秒前
今后的应助被光亮的天与采纳,获得100
3秒前
丘比特的应助被执着草丛采纳,获得10
3秒前
顺顺顺完成签到,获得积分10
3秒前
英俊的铭的应助被小北采纳,获得10
4秒前
4秒前
大模型的应助被滕滕滕采纳,获得10
5秒前
5秒前
Zxz发布了新的文献求助20
6秒前
仁爱的老太完成签到 ,获得积分10
7秒前
晚风完成签到,获得积分10
7秒前
清秀的梦安完成签到,获得积分10
7秒前
8秒前
walter发布了新的文献求助10
8秒前
9秒前
Crssss的应助被wzm采纳,获得100
9秒前
Callan完成签到,获得积分10
9秒前
科研通AI6.4的应助被gfhdf采纳,获得10
10秒前
ding的应助被易木采纳,获得10
11秒前
11秒前
璃茉完成签到,获得积分10
12秒前
一口辰发布了新的文献求助20
12秒前
13秒前
eiland完成签到,获得积分10
13秒前
Lucas的应助被虎鲸_thEt采纳,获得10
13秒前
14秒前
16秒前
16秒前
含蓄灵阳完成签到 ,获得积分10
17秒前
SZH发布了新的文献求助10
18秒前
很拉风旅行包完成签到,获得积分10
18秒前
infinite完成签到,获得积分10
18秒前
深情安青的应助被健忘的星星采纳,获得10
19秒前
NAN发布了新的文献求助10
19秒前
hyyy发布了新的文献求助10
20秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
Grapes 1000
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8178807
求助须知:如何正确求助?哪些是违规求助? 9569558
关于积分的说明 21805222
捐赠科研通 7773974
什么是DOI,文献DOI怎么找? 3432933
关于科研通互助平台的介绍 2556873
邀请新用户注册赠送积分活动 2478593